Fig. 2From: Utility of posaconazole therapeutic drug monitoring and assessment of plasma concentration threshold for effective prophylaxis of invasive fungal infections: a meta-analysis with trial sequential analysisMeta-analysis for successful outcome among patients with steady-state posaconazole plasma concentration ≥ 0.5 mg/L compared with patients with < 0.5 mg/LBack to article page